The Role of Integrative Medicine in Cancer |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
Molecular Testing Updates and Impact for Clinical Practice |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
NCCN Guidelines® Insights - Primary Cutaneous Lymphomas, Version 2.2020 |
1.00 |
05/10/2020 - 12:00am to 05/10/2021 - 12:00am |
New Approaches to Multiple Myeloma Therapy |
1.00 |
05/12/2020 - 12:00am to 05/12/2021 - 12:00am |
Recognition and Management of Graft Versus Host Disease |
1.00 |
05/12/2020 - 12:00am to 03/01/2021 - 12:00am |
Current Insights: Evolving Principles and Controversies of Cancer Risk Assessment and Management of Hereditary Cancers |
1.25 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Advances in the Management of Pancreatic Adenocarcinoma |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Cardiovascular Health and Risk Management in Cancer Survivors |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Current Topics in Management of Non-Muscle Invasive Bladder Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Emerging Treatment Options for the Management of Metastatic Colorectal Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Implementing Clinical Trials in the Community Setting |
0.50 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Management of Gliomas: Individualized Treatment Options |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Management of Metastatic Breast Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Multidisciplinary Management of Advanced Kidney Cancer |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |